Edwards Lifesciences (EW)

About Edwards Lifesciences (EW)

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Details

Daily high

$87.20

Daily low

$85.46

Price at open

$86.19

52 Week High

$89.60

52 Week Low

$72.30

Market cap

49.4B

Dividend yield

0.00%

Volume

3.7M

Avg. volume

5.3M

P/E ratio

46.66

Edwards Lifesciences News